Raymond James & Associates’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-28,349
| Closed | -$474K | – | 3589 |
|
|
2020
Q2 | $474K | Buy |
28,349
+16,727
| +144% | +$280K | ﹤0.01% | 2608 |
|
|
2020
Q1 | $168K | Sell |
11,622
-16,237
| -58% | -$235K | ﹤0.01% | 3075 |
|
|
2019
Q4 | $932K | Buy |
27,859
+2,274
| +9% | +$76.1K | ﹤0.01% | 2302 |
|
|
2019
Q3 | $536K | Sell |
25,585
-15,980
| -38% | -$335K | ﹤0.01% | 2596 |
|
|
2019
Q2 | $865K | Sell |
41,565
-12,399
| -23% | -$258K | ﹤0.01% | 2294 |
|
|
2019
Q1 | $1.21M | Buy |
53,964
+7,581
| +16% | +$169K | ﹤0.01% | 2086 |
|
|
2018
Q4 | $1.11M | Sell |
46,383
-4,959
| -10% | -$119K | ﹤0.01% | 2023 |
|
|
2018
Q3 | $1.4M | Sell |
51,342
-2,766
| -5% | -$75.5K | ﹤0.01% | 2029 |
|
|
2018
Q2 | $1.46M | Buy |
54,108
+5,612
| +12% | +$151K | ﹤0.01% | 1969 |
|
|
2018
Q1 | $1.54M | Buy |
48,496
+23,759
| +96% | +$756K | ﹤0.01% | 1855 |
|
|
2017
Q4 | $936K | Buy |
24,737
+1,669
| +7% | +$63.2K | ﹤0.01% | 2160 |
|
|
2017
Q3 | $572K | Buy |
23,068
+51
| +0.2% | +$1.27K | ﹤0.01% | 2398 |
|
|
2017
Q2 | $473K | Buy |
23,017
+4,982
| +28% | +$102K | ﹤0.01% | 2443 |
|
|
2017
Q1 | $392K | Buy |
18,035
+775
| +4% | +$16.8K | ﹤0.01% | 2531 |
|
|
2016
Q4 | $353K | Buy |
17,260
+126
| +0.7% | +$2.58K | ﹤0.01% | 2531 |
|
|
2016
Q3 | $257K | Buy |
17,134
+4,843
| +39% | +$72.6K | ﹤0.01% | 2704 |
|
|
2016
Q2 | $133K | Sell |
12,291
-65
| -0.5% | -$703 | ﹤0.01% | 2735 |
|
|
2016
Q1 | $168K | Buy |
+12,356
| New | +$168K | ﹤0.01% | 2609 |
|